Related Experiment Video
Updated: Aug 1, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Strategies for treatment-resistant depression
1University of Illinois at Chicago, USA.
Clinical Cornerstone
|February 22, 2000
Summary
Clinical depression is a serious, often underestimated disorder impacting overall health and increasing suicide risk. This review outlines strategies for treating resistant depression when initial therapies fail.
Area of Science:
- Psychiatry and Mental Health
- Clinical Medicine
Background:
- Clinical depression is a prevalent mental health disorder with significant implications for patient well-being and mortality.
- Major depressive disorder is linked to over 50% of suicides and negatively affects other medical conditions.
- Despite high response rates to medication (>=70%), many patients do not receive adequate depression treatment.
Purpose of the Study:
- To define adequate therapy for major depressive disorder.
- To discuss common comorbid conditions associated with depression.
- To examine the concept of true treatment resistance in depression management.
Main Methods:
- Review of existing literature on depression treatment.
- Analysis of definitions for adequate and resistant depression therapy.
- Development of a treatment algorithm for treatment-resistant depression.
Main Results:
- Adequate therapy for depression involves appropriate medication selection and dosage.
- Treatment resistance can be influenced by comorbid conditions and diagnostic accuracy.
- Effective strategies for treatment-resistant depression include medication class switching, combination therapy, augmentation, and somatic therapies.
Conclusions:
- Accurate diagnosis and adequate initial therapy are crucial for managing clinical depression.
- A systematic approach, including a treatment algorithm, can guide clinicians in managing treatment-resistant depression.
- Addressing comorbid conditions and exploring diverse therapeutic strategies are key to improving patient outcomes.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:24Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...